Apeneta 250 mg tablete s produljenim oslobađanjem
| Name | Apeneta 250 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-442471307 |
| Active Substance | tapentadolmaleat hemihidrat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 250 mg tapentadola (u obliku tapentadolmaleata hemihidrata) |
| Pharmaceutical Form | Tableta s produljenim oslobađanjem |
| Manufacturer | TAD Pharma Gmbh, Cuxhaven, Njemačka Krka d.d., Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 03.08.2021 |
| MA Period of Validity | 03.08.2026 |
| Classification Number | UP/I-530-09/20-01/65 |
| Registration Number | 381-12-01/154-21-02 |
| Prescription | na recept |
| Type of prescription | poseban recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N02AX06 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
